Report Categories
View AllRecent Articles
View All
NVCT Nuvectis Pharma posts slight Q4 2025 EPS miss yet shares edge higher on positive investor sentiment
The MA impact hidden in Weave Communications WEAV earnings Weave Communications Delivers 293 EPS Estimate Beat
NEON Neonode reports wider than expected Q4 2025 loss shares edge down 178 percent on soft quarterly results
What short sale restriction Immunocore IMCR Technical Weakness 20260429